相关实验视频
Updated: Jul 14, 2026

05:37
Intravitreous Injection for Establishing Ocular Diseases Model
Published on: October 1, 2007
写给编辑的信:关于Palmieri等人的评论. "的"Faricimab静脉内注射后的阴道炎:一个病例报告"
Nicolas Nicolaou1, Despina Nicolaou1, Savvas Christou2
1Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.
Ocular immunology and inflammation
|December 29, 2025
概括
眼内炎症 (IOI) 可能发生在内法利西马布注射后,呈现急性或延迟. 早期识别和迅速管理对于有利的结果至关重要.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
背景情况:
- 静脉内注射是对视网膜疾病的常见治疗方法.
- 法里西马布是一种针对Ang-2和VEGF-A的新型双特异抗体.
- 无菌眼内炎症 (IOI) 是静脉内注射的潜在并发症.
研究的目的:
- 描述隔离的前性脑膜炎和内性脑膜炎的表现和管理,在内性脑膜炎之后.
- 要突出与法里西马布治疗相关的关键特征和潜在并发症.
主要方法:
- 对IOI后静脉内膜外科病例的回顾性分析.
- 审查了临床表现,发病时间和管理策略.
主要成果:
- IOI的发病时间在注射后1-35天之间,观察到急性 (<5天) 和延迟 (~14天) 的模式.
- 延迟发作的IOI表明是一种IV型过敏反应.
- 法里西马布的双重抑制可能会增加单纯疹病毒重新激活的风险.
结论:
- 在法里西马布之后的无菌IOI需要及时诊断和管理.
- 需要对疹再激活保持警,并建议预防性抗病毒疗法.
- 应根据IOI的严重程度量身定制管理,考虑诊断点击以排除感染.
相关概念视频
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

